New 'flexible' treatment option for rheumatoid arthritis
A subcutaneous formulation of tocilizumab (RoActemra) has been launched, giving rheumatoid arthritis patients the option to be treated at home as well as hospital.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units